Drug interaction between itraconazole and sirolimus in a primary renal allograft recipient [3]

Transplantation

Volumn 79, Issue 6, 2005, Pages 737-

  Kuypers, Dirk R ^a   Claes, Katleen ^a   Evenepoel, Pieter ^a   Maes, Bart ^a   Vandecasteele, Stefaan ^a   Vanrenterghem, Yves ^a   Van Damme, Boudewijn ^a   Desmet, Koenraad ^a  

^a UNIVERSITY HOSPITALS LEUVEN   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIFUNGAL AGENT; BASILIXIMAB; CALCINEURIN INHIBITOR; CORTICOSTEROID; FLUCONAZOLE; ITRACONAZOLE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; RAPAMYCIN;

ADULT; CADAVER DONOR; CASE REPORT; DOSE RESPONSE; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY ALLOGRAFT; KIDNEY FAILURE; LETTER; MYCOSIS; PRIORITY JOURNAL; SEPTICEMIA; THROMBOTIC THROMBOCYTOPENIC PURPURA;

DRUG INTERACTIONS; FEMALE; HUMANS; ITRACONAZOLE; KIDNEY TRANSPLANTATION; MIDDLE AGED; SIROLIMUS; TRANSPLANTATION; TRANSPLANTATION, HOMOLOGOUS;

EID: 16244391778     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.TP.0000147462.86886.F3     Document Type: Letter

References (3)

1. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
2. Kovarik JM, Hsu CH, McMahon L, et al. Population pharmacokinetics of everolimus in de novo renal transplant patients: impact of ethnicity and comedications. Clin Pharmacol Ther 2001; 70: 247.
3. Cervelli MJ. Fluconazole-sirolimus drug interaction. Transplantation 2002; 74: 1477.